Twitter Feed
@ewarren ("Elizabeth Warren") wrote:
For years, Merck brought in billions from one cancer drug. But its patent will expire soon, which means competitors could bring down costs. Now Merck’s trying to patent a slightly tweaked version just in time to protect their monopoly. I’m calling it out: https://www.reuters.com/world/us/senator-warren-urges-us-patent-office-scrutinize-mercks-keytruda-2023-02-23/